Skip to content

A Multicenter Randomized Trial of Perioperative Fluid Therapy for Chronic Liver Disease Based on a Multimodal Large Language Model

A Multicenter Randomized Trial of Perioperative Fluid Therapy for Chronic Liver Disease Based on a Multimodal Large Language Model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100087
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease

Interventions

Large Model-assisted Group:Perioperative fluid therapy assisted by a large model.
Usual Care Group:Conventional Perioperative Fluid Management.

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 80 years;Patients with chronic liver disease in the preoperative period, that is, those whose diagnosis includes viral hepatitis, metabolic liver disease, drug-induced liver injury, autoimmune hepatitis, or other chronic liver conditions with a disease duration of more than six months, or those with unknown disease duration but with imaging or pathological evidence of cirrhotic changes;Patients undergoing elective surgery: American Society of Anesthesiologists (ASA) physical status classification of II to IV; 2.General anesthesia planned, with an anticipated surgical duration exceeding 3 hours and an expected postoperative hospital stay exceeding 5 days.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria include patients with severe preoperative cardiovascular and cerebrovascular diseases or renal dysfunction; 2.Patients experiencing critical intraoperative events such as cardiac arrest or refractory anaphylactic shock; 3.Patients with compromised mental status, mental disorders, or lack of self-control; 4.Those who refuse to participate or whose family members decline participation.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative complications graded III or higher according to the Clavien-Dindo classification.;

Secondary

MeasureTime frame
Postoperative hospital stay duration;Liver failure after hepatectomy;Postoperative pulmonary complications;Postoperative acute kidney injury;

Countries

China

Contacts

Public ContactBin Yi

The First Affiliated Hospital of Army Medical University

yibin1974@163.com+86 13508370131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026